Instituto De Investigación Hospital Universitario La Paz
Clinical trials sponsored by Instituto De Investigación Hospital Universitario La Paz, explained in plain language.
-
Gene test before kidney transplant could personalize Anti-Rejection drugs
Disease control Recruiting nowThis study tests whether doing a genetic test before a kidney transplant can help doctors choose the best starting dose of tacrolimus, a drug that prevents organ rejection. About 114 adults waiting for a kidney transplant will be randomly assigned to either standard care or a gen…
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
New CART therapy offers hope for young leukemia patients with no other options
Disease control Recruiting nowThis early-phase trial tests whether a new type of CART cell therapy is safe and possible for children, teens, and young adults with leukemia that has come back or not responded to standard treatments. The study includes two different CART products based on the specific type of l…
Phase: PHASE1 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
New sedation method could help ICU patients breathe on their own sooner
Symptom relief Recruiting nowThis study tests if a gas sedative (isoflurane) given through a breathing tube works better than standard IV sedation (propofol) for critically ill patients. About 620 adults who need deep sedation and a breathing machine for more than 48 hours will be randomly assigned to one of…
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Symptom relief
Last updated Jun 08, 2026 13:05 UTC